The National Thoroughbred Racing Association (NTRA) reports that the effort to adopt uniform national reforms addressing changes to medication regulation, enforcement, and laboratory testing continues to gain support.

As of Nov. 1, the new medication reforms that are a central component of the reform effort have been adopted by Delaware, Maryland, Massachusetts, New Jersey, New York, Pennsylvania, Texas, Virginia, and West Virginia. The rules are currently under consideration in Arkansas, California, Idaho, Illinois, Indiana, Kentucky, Minnesota, Ohio, New Mexico, and Wyoming, according to the NTRA press release.

In addition, three laboratories that conduct equine drug testing for six racing jurisdictions have received accreditation from the Racing Medication and Testing Consortium (RMTC) and laboratories conducting testing for 19 other racing states have applied for RMTC accreditation. Laboratories receiving full RMTC accreditation are the University of California, Davis (which tests samples for racehorses in California and New Mexico), and HSL Sports Science (which conducts testing for Kentucky, Maine, and Virginia) in Lexington, Ky. The Ohio Department of Agriculture has been granted interim accreditation by the RMTC, with only a site inspection remaining before it receives a full accreditation designation.

The labs that have applied for RMTC accreditation are Industrial Laboratories (which conducts testing for Arizona, Colorado, Minnesota, North Dakota, Oklahoma, and Wyoming), Truesdail Laboratories (Arkansas, Idaho, Indiana, Massachusetts, Nebraska, New Jersey, Oregon and Washington), Dalare Associates (Delaware and West Virginia), the New York Drug Testing and Research Program (New York), and the Pennsylvania Equine Toxicology and Research Laboratory (Pennsylvania)